FeesSafety
Pluang+

Bitcoin shows rising concentration near $83K-$84K, signaling possible market volatility soon.

Technical Signals
04 Oct 2026, 05:16 WIB
Tokenpost
View Source
Neutral
Bitcoin shows rising concentration near $83K-$84K, signaling possible market volatility soon.

Bitcoin's daily chart revealed doji candles with about 1.52 million BTC concentrated in the $83,000-$84,000 price range on October 3. This 12% concentration is slightly lower than the 12.9% seen in early August around $62,000-$63,000, after which BTC surged from $60,000 to $80,000 in 17 days. Analyst Murphy noted that while rising concentration doesn't predict market direction, it suggests increased volatility is likely, with significant market moves possible within one to two months.

Bitcoin concentration data is the subject, provided here as market context. For readers following major cryptocurrencies, 32 of 50 rose and 17 fell on Pluang as of Oct 04, 2026 08:51 WIB. ENJ fell 5.49% to Rp594 with 58% buy orders, COMP rose 5.10% to Rp455,795 with 56% sell orders, and YFI rose 4.23% to Rp47,022,415 with 82% sell orders.

More News

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...

Market News
Neutral
35 minutes ago
SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...

Company Fundamentals
Bullish
1 hour ago
All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

All patients in Alpha Tau's glioblastoma trial alive with 100% tumor response and no serious side effects

Alpha Tau Medical announced interim results from its U.S. trial of Alpha DaRT therapy for recurrent glioblastoma, showing all eight treated patients are alive with a median follow-up of 6.9 months and no median survival reached. Among six patients as...

Market News
Bullish
5 hours ago
Ethereum delays Glamsterdam test on Hoodi due to smart contract compatibility concerns.

Ethereum delays Glamsterdam test on Hoodi due to smart contract compatibility concerns.

Ethereum developers have postponed the planned Glamsterdam network activation on Hoodi, originally set for October 26. The delay is to allow further investigation into how the new EIP-8037 proposal interacts with existing smart contracts. This pause ...

Protocol Fundamentals
Bearish
5 hours ago
Tesla and SpaceX lose $420B in market value after Democrats win midterms amid probe fears

Tesla and SpaceX lose $420B in market value after Democrats win midterms amid probe fears

Tesla and SpaceX saw a combined market value drop of over $420 billion within two days following the Democratic Party's sweep in the midterm elections. Investors are concerned that the new Democratic-controlled Congress may initiate investigations in...

Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App